The Indian drug industry's dream of coming out with an own new chemical entity or an originally researched new drug has received a big boost. Balaglitazone, the diabetic drug molecule being......
Stringent regulatory norms and the financial impact of the global credit crisis on some research companies may hurt half a dozen molecules of Indian companies, such as Glenmark, Nicholas Piramal......
Dr Reddy's Laboratories hopes to become a true drug discovery company in the near future, said chairman K Anji Reddy and chief executive officer GV Prasad at the 24th annual general body meeting in......
The Denmark-based Novo Nordisk, the world's largest insulin manufacturer, is developing a new anti-diabetes tablet -- an insulin sensitiser (Balaglitazone) -- in association with Dr Reddy's......